Jubilant Ingrevia to acquire Strategic Equity Stake in Zettaone Technologies
Jubilant Ingrevia (JUBLINGREA) said it has agreed a deal to acquire Strategic Equity Stake in Zettaone Technologies. The company is valued at about ₹9,387 crore.
What happened
Jubilant Ingrevia (JUBLINGREA) told the exchanges on 8 November 2026 at 07:28 PM that it has agreed a deal to acquire Strategic Equity Stake in Zettaone Technologies.
From the filing: "Through this acquisition, the Company, via JAEL, has entered the rapidly growing Electronics Design and Manufacturing Services (EDMS) sector, which will open a large opportunity for the Company."
Company snapshot
Jubilant Ingrevia is a small-cap company in the Chemicals sector, with a market value of about ₹9,387 crore.
The stock last traded at ₹589.4, against a 52-week range of ₹537.3–₹795 (25.9% below the high).
Before this filing the shares had moved −10.9% over the month and −22.7% over three months. Average daily turnover over the last 20 sessions was about ₹31.38 crore.
Promoters held 45.22% at the end of Q2 FY27; 9.30% of promoter shares were pledged. Foreign institutions owned 6.94% and domestic institutions 25.17%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 1,121 | 69.5 | 4.4 |
| Q3 FY26 | 1,051 | 46.9 | 2.97 |
| Q4 FY26 | 1,179 | 86.4 | 5.47 |
| Q1 FY27 | 1,300 | 105.8 | 6.7 |
| Q2 FY27 | 1,394 | 111.4 | 7.07 |
What history shows
This is not the company's first m&a disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 0.3% on average the next trading day and was down 2.2% on average after five days (3 filings with price data).
Across 59 similar disclosures by other Chemicals companies, shares moved −0.9% on average the next day and −1.2% over five days; 34% of them rose the next day.
Market-wide, 2,377 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 1 Oct 2026 | Incorporation of Wholly Owned Subsidiary | +1.0% | −1.6% |
| 18 Aug 2026 | A press release dated August 18, 2026, titled "Jubilant Ingrevia… | −0.9% | −2.6% |
| 18 Aug 2026 | M&A | −0.9% | −2.6% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
- East Bridge Capital Management buys 0.6% stake in Jubilant Ingrevia
- Jubilant Ingrevia Q2 net profit surges 60% to ₹111 cr
- Jubilant Ingrevia Q2 results: Stock gains as much as 8% after Nutrition & Health Solutions aid earnings growth
- Earnings call transcript: Jubilant Ingrevia posts strong Q2 2027 growth By Investing.com
- Jubilant Ingrevia Ltd (BOM:543271) Q2 2027 Earnings Call Highlights: Record Revenue of INR ...
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.